• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

OutSee: Venture Capital Funding History

OutSee

To add a bio or update company history, please click update information.

News from OutSee

    OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discoveryOutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
    OutSee
    24 Jun 2025

    OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery

    OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.

    OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platformOutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
    OutSee
    12 Jan 2026

    OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform

    OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.

OutSee
  • Life Sciences
  • Cambridge, United Kingdom
  • £4.3m
  • outsee.co.uk
  • Update Information

More venture news

  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
    Neobe Therapeutics
    10 Nov 2026

    Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

    SeedLife Sciences
  • PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
    PhaSER Biomedical
    9 Nov 2026

    PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases

    GrantLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn